Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Farhad Ravandi, Susan M. O'Brien, Jorge E. Cortes, Deborah M. Thomas, Rebecca Garris, Stefan Faderl, Jan A. Burger, Michael E. Rytting, Alessandra Ferrajoli, William G. Wierda, Srdan Verstovsek, Richard Champlin, Partow Kebriaei, Deborah A. Mccue, Xuelin Huang, Elias Jabbour, Guillermo Garcia-Manero, Zeev Estrov, Hagop M. Kantarjian

Research output: Contribution to journalArticlepeer-review

91 Scopus citations

Fingerprint Dive into the research topics of 'Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences